Today: 9 June 2026
Browse Category

NASDAQ:NUAI 26 September 2025 - 1 June 2026

New Era Energy stock jumps as Russell index addition approaches

New Era Energy stock jumps as Russell index addition approaches

New Era Energy & Digital shares soared 20% to $5.75 after the company said it expects to join the Russell 3000 and Microcap indexes. Over 15.7 million shares traded. FTSE Russell’s first lists confirm NUAI as an addition. New Era recently expanded its Texas data center site to nearly 492 acres, closed a $115 million equity raise, and secured a $290 million credit line. Risks include project financing, operations, and pending litigation.
1 June 2026
NUAI Stock Soars on Texas AI Campus Expansion: New Era Energy & Digital Update for November 25, 2025

NUAI Stock Soars on Texas AI Campus Expansion: New Era Energy & Digital Update for November 25, 2025

New Era Energy & Digital (NASDAQ: NUAI) closed Monday at $4.40, up 15.8% after announcing its Texas AI data center campus will expand to 438 acres. Trading volume reached 8.6 million shares. Despite the rally, NUAI shares remain down about 62% over the past year. The company reported $0.84 million in revenue and a $23.5 million net loss for the past 12 months.
New Era Energy & Digital (NUAI) Stock Skyrockets on AI Data Center Dreams – Key Updates & Outlook

NUAI Stock Soars 185% on Texas AI Data Center Pivot – Hype or Opportunity?

New Era Energy & Digital (NASDAQ: NUAI) shares surged 186% in mid-October after announcing Phase Two engineering for its Texas AI data center joint venture with Sharon AI. The TCDC campus is expanding to 438 acres, targeting 1GW capacity, with on-site gas power and 1,600 miles of fiber planned. NUAI paid off convertible debt, raised $13.8M in equity, and ended plans for further share sales. The company regained Nasdaq compliance.
NUAI Stock Rockets on AI Data Center Pivot – What Investors Need to Know

NUAI Stock Rockets on AI Data Center Pivot – What Investors Need to Know

NUAI shares closed at $4.55 on Oct. 17, up 44% for the day and 186% over two weeks, pushing market cap to around $120–130 million, a 52-week high. The company, now New Era Energy & Digital, rebranded in September and advanced its Texas AI data center project. NUAI remains pre-revenue, with Q2 sales of $0.53 million and a net loss of $3.6 million. Analysts warn the surge is driven by speculation and caution investors.
New Era Energy (NUAI) Stock Skyrockets on AI Data Center Pivot – Can the Rally Last?

New Era Energy (NUAI) Stock Skyrockets on AI Data Center Pivot – Can the Rally Last?

New Era Energy & Digital (NASDAQ: NUAI) closed at $4.55 on Oct. 17, up 44% for the day and 186% in two weeks, after announcing progress on its Texas AI data center project. The company regained Nasdaq compliance, ended plans for a new share sale, and now claims to be sufficiently funded. Market cap stands near $129 million. New Era remains pre-revenue, with heavy trading volume and ongoing volatility.
New Era Energy & Digital (NUAI) Skyrockets 185% on AI Data Center Buzz – Can the Tiny Stock Sustain the Hype?

New Era Energy & Digital (NUAI) Skyrockets 185% on AI Data Center Buzz – Can the Tiny Stock Sustain the Hype?

New Era Energy & Digital (NASDAQ: NUAI) closed at $4.55 on Oct. 17, up 44% in one day and 186% in two weeks after announcing progress on its 1-gigawatt AI data center in Texas. The company regained Nasdaq compliance, ended plans for share dilution, and rebranded from helium to AI infrastructure in August. NUAI remains pre-revenue, with $0.7 million in annual sales and steep losses. The stock is up 1300% from its 52-week low.
NUAI Stock Rockets 85% on AI Data Center News – Is the Rally Sustainable?

NUAI Stock Rockets 85% on AI Data Center News – Is the Rally Sustainable?

NUAI shares jumped nearly 90% on Oct. 9 after New Era began Phase Two engineering at its 1-gigawatt Texas AI data center. The company restored Nasdaq compliance on Oct. 10, canceling a delisting hearing. NUAI closed at $3.30 on Oct. 14, up 80% from a week earlier. Analysts caution the surge is fueled by momentum and aggressive marketing as much as fundamentals.
NUAI Stock Skyrockets: Tiny Permian Data Center Bet Surges 84% on AI Hype

NUAI Stock Skyrockets: Tiny Permian Data Center Bet Surges 84% on AI Hype

NUAI shares surged 83.8% to close at $2.83 on Oct. 9, 2025, following news of Phase One completion and Phase Two launch at its Texas Critical Data Centers joint venture. Market cap rose to $73–80 million. The company, now focused on AI data centers, recently appealed a Nasdaq delisting notice and claims to meet equity requirements after raising $13.8 million. Q2 revenue was $0.53 million against a net loss of $3.6 million.
New Era Energy & Digital (NUAI) Stock Skyrockets on AI Data Center Dreams – Key Updates & Outlook

New Era Energy & Digital (NUAI) Stock Skyrockets on AI Data Center Dreams – Key Updates & Outlook

New Era Energy & Digital (NASDAQ: NUAI) shares jumped nearly 90% on Oct. 9, 2025, after announcing progress on its 1GW AI data center project in West Texas. The company, rebranded from New Era Helium in August, faces a Nasdaq delisting hearing on Oct. 16 despite recent financial moves and a brief market cap surge above $75 million.
NUAI Rockets Nearly 50% in a Day After AI Data‑Center Milestone—What Changed on Sept. 25–26 and What Could Break Next

NUAI Rockets Nearly 50% in a Day After AI Data‑Center Milestone—What Changed on Sept. 25–26 and What Could Break Next

New Era Energy & Digital (NASDAQ: NUAI) surged 49.8% to $1.38 on Sept. 25, trading 76.6 million shares after media coverage highlighted completion of Phase One engineering for its Texas Critical Data Centers JV. Pre-market quotes early Sept. 26 reached $1.86. The company faces a Nasdaq listing risk after a staff determination letter on Sept. 5. TCDC aims for 1 GW of AI data-center capacity with initial power targeted for early 2027.
26 September 2025

Stock Market Today

  • Nuvalent Shares Surge Near $124 Following GSK's $10.6 Billion Buyout Offer
    June 9, 2026, 10:35 AM EDT. Nuvalent's stock jumped 38.9% to $122.93 after GSK announced a $10.6 billion cash acquisition at $124 per share, reflecting a 40% premium to the last close. The deal highlights GSK's strategic move to expand its oncology portfolio beyond its current 6% share of sales, aiming to capitalize on Nuvalent's two lung cancer drugs pending FDA decisions this year. The tender offer needs the approval of at least half of Nuvalent's Class A shares and U.S. antitrust clearance. Early analyst reactions included target price adjustments but echoed caution over valuation. Nuvalent's pipeline products could face competition from existing ALK-targeted therapies by Pfizer and Roche.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Go toTop